Transforming the landscape of multiple myeloma (MM) with CAR T-cell therapies FINAL


Learning objective:

After attending this symposium delegates should be able to:

  • Describe how CAR T-cell therapies are advancing the treatment options for patients with MM
  • Discuss practical considerations about the use of CAR T-cell therapy for patients with MM



  • Philippe Moreau (France)
  • Kwee Yong (UK)
  • Inger Nijhof (The Netherlands)


More Info
30 Minutes
EM-89024 - Date of preparation: February 2022